JP2003506047A - マイクロカプセル封入した酸化窒素シンターゼ源 - Google Patents
マイクロカプセル封入した酸化窒素シンターゼ源Info
- Publication number
- JP2003506047A JP2003506047A JP2001514134A JP2001514134A JP2003506047A JP 2003506047 A JP2003506047 A JP 2003506047A JP 2001514134 A JP2001514134 A JP 2001514134A JP 2001514134 A JP2001514134 A JP 2001514134A JP 2003506047 A JP2003506047 A JP 2003506047A
- Authority
- JP
- Japan
- Prior art keywords
- microcapsules
- cells
- nos
- ecdysone
- microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9918076.2 | 1999-07-30 | ||
GBGB9918076.2A GB9918076D0 (en) | 1999-07-30 | 1999-07-30 | Microencapsulated nitric oxide synthase source |
GB0016172.9 | 2000-06-30 | ||
GB0016172A GB0016172D0 (en) | 2000-06-30 | 2000-06-30 | Microencapsulated nitric oxide synthase source |
PCT/GB2000/002924 WO2001009342A1 (fr) | 1999-07-30 | 2000-07-28 | Source de synthase d'oxyde nitrique microencapsulee |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003506047A true JP2003506047A (ja) | 2003-02-18 |
Family
ID=26244581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001514134A Pending JP2003506047A (ja) | 1999-07-30 | 2000-07-28 | マイクロカプセル封入した酸化窒素シンターゼ源 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1203084A1 (fr) |
JP (1) | JP2003506047A (fr) |
AU (1) | AU6174500A (fr) |
CA (1) | CA2380787A1 (fr) |
WO (1) | WO2001009342A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019014754A (ja) * | 2013-03-14 | 2019-01-31 | マサチューセッツ インスティテュート オブ テクノロジー | 細胞の封入および細胞集合体のための多層ヒドロゲルカプセル |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT105489B (pt) * | 2011-01-18 | 2014-05-13 | Ass For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies A4Tec | Dispositivo, método e sistema de fabrico de microcápsulas |
CN115487779B (zh) * | 2022-06-01 | 2023-07-28 | 同济大学 | 一种二价铁离子/纤维素纳米晶体/海藻酸钠复合材料的制备方法及对四环素的吸附应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800829A (en) * | 1991-04-25 | 1998-09-01 | Brown University Research Foundation | Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
US5658565A (en) * | 1994-06-24 | 1997-08-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Inducible nitric oxide synthase gene for treatment of disease |
US5972650A (en) * | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
US6333318B1 (en) * | 1998-05-14 | 2001-12-25 | The Salk Institute For Biological Studies | Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
-
2000
- 2000-07-28 JP JP2001514134A patent/JP2003506047A/ja active Pending
- 2000-07-28 WO PCT/GB2000/002924 patent/WO2001009342A1/fr not_active Application Discontinuation
- 2000-07-28 AU AU61745/00A patent/AU6174500A/en not_active Abandoned
- 2000-07-28 CA CA002380787A patent/CA2380787A1/fr not_active Abandoned
- 2000-07-28 EP EP00948182A patent/EP1203084A1/fr not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019014754A (ja) * | 2013-03-14 | 2019-01-31 | マサチューセッツ インスティテュート オブ テクノロジー | 細胞の封入および細胞集合体のための多層ヒドロゲルカプセル |
Also Published As
Publication number | Publication date |
---|---|
WO2001009342A1 (fr) | 2001-02-08 |
AU6174500A (en) | 2001-02-19 |
EP1203084A1 (fr) | 2002-05-08 |
CA2380787A1 (fr) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11344504B1 (en) | Combinations of mRNAs encoding immune modulating polypeptides and uses thereof | |
US7306799B2 (en) | Use of VEGF inhibitors for treatment of eye disorders | |
CN102695525B (zh) | 用于蛋白质表达的具有未修饰和修饰核苷酸的组合的rna | |
CN104114572A (zh) | 经修饰的核苷、核苷酸和核酸组合物 | |
US20050202075A1 (en) | Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers | |
JP2002521044A (ja) | 傷ついた組織に対するターゲッティング医薬品剤 | |
JP2000507456A (ja) | 拮抗的特性を有する血管内皮細胞増殖因子の変異体 | |
JP2010540534A (ja) | 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用 | |
JP2018528168A (ja) | 新血管生成抑制のための血管内皮成長因子受容体ターゲッティングペプチド−エラスチン融合ポリペプチド及び自己組立ナノ構造体 | |
JP4493854B2 (ja) | リガンドの生物学的活性を増強する方法 | |
HU228898B1 (en) | Vascular endothelial cell growth factor variants and uses thereof | |
JP2023548957A (ja) | 新型PiggyBacトランスポゾンシステム及びその適用 | |
WO2017071173A1 (fr) | Agent thérapeutique antitumoral modifié par protéine de fusion il-12/cd62l, son procédé de préparation et son utilisation | |
CN101573445A (zh) | 由胰腺腺泡细胞向胰岛素生成细胞的体内转化 | |
JP2003506047A (ja) | マイクロカプセル封入した酸化窒素シンターゼ源 | |
WO2023099884A1 (fr) | Compositions d'arnsa de pax6 et procédés d'utilisation | |
CN114426573B (zh) | 一种Nur77磷酸化衍生肽及其在制备促进胚胎植入的药物中的应用 | |
WO2017159540A1 (fr) | Protéine de fusion albumine sérique-hormone de croissance 20k | |
KR20040097249A (ko) | 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제 | |
CN112812182A (zh) | 一种靶向fgfr4的单链抗体、嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用 | |
JP2002527112A (ja) | ブタソマトトロピンのデリバリーシステム | |
CN112979827A (zh) | 一种抗EGFR scFv::FTH1/FTH1蛋白纳米粒子的应用 | |
CN100384865C (zh) | 用于rna干扰的治疗用途的方法及组合物 | |
CN116917309A (zh) | 表达构建体及其用途 | |
WO2017117890A1 (fr) | Protéine de fusion il-12/cd107a, son procédé de préparation et utilisation |